Neovasc Inc. (NVCN) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET

Company Participants

Mike Cavanaugh - Investor Relations

Fred Colen - President & Chief Executive Officer

Chris Clark - Chief Financial Officer

Conference Call Participants

David Martin - Bloom Burton

Operator

Good day, and welcome to the Neovasc Incorporated Third Quarter Earnings Call. At this time, I will turn the call over to Mark Cavanaugh. Please go ahead.

Mike Cavanaugh

Good afternoon. I’d like to thank everyone for joining us today. Earlier today, Neovasc Incorporated issued a press release announcing our financial results for the quarter ended September 30, 2022 and describing the company’s recent business highlight. You can access the copy of the announcement on the company’s website at www.neovas.com/investors. With me on the call today are Fred Colen, President and Chief Executive Officer; and Chris Clark, Chief Financial Officer.

I would like to remind everyone that management will be making statements during this call that include forward-looking statements within the meaning of applicable securities laws, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995 and Canadian Securities Laws. Any statements contained in this call that are not statements of historical facts should be deemed to be forward-looking statements.

All forward-looking statements, including, without limitation, our examination of historical operating trends, expectations regarding coverage and approval decisions, pricing and enrollment matters; our value creation strategies, the benefits of our products and our future financial expectations and results are based upon current estimates and various assumptions. Words such as expect, anticipate, estimate, outlook, will, may, should, continue, strategy, potential, intend, try, believe, plan and similar words or expressions are meant to identify forward-looking statements. These statements involve material risks and uncertainties that could cause actual results to differ materially from those anticipated or implied by these forward-looking statements. Accordingly, you should not place undue reliance on these statements.

For more information on risks and uncertainties related to these forward-looking statements, please refer to the cautionary note regarding forward-looking statements and Risk Factors sections of Neovasc's Annual Report on Form 20-F and the discussion in Neovasc's MD&A, which are available on EDGAR and SEDAR. The information provided in this conference call speaks only to the live broadcast today, November 10, 2022.

Neovasc disclaims any intention or obligation, except as required by law, to update or revise any information or forward-looking statements, whether because of new information, future events or otherwise.